Abstract
Background: The duration of humoral and T and B cell response after the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear.
Methods: We performed a cross-sectional study to assess the virus-specific antibody and memory T and B cell responses in coronavirus disease 2019 (COVID-19) patients up to 343 days after infection. Neutralizing antibodies and antibodies against the receptor-binding domain, spike, and nucleoprotein of SARS-CoV-2 were measured. Virus-specific memory T and B cell responses were analyzed.
Results: We enrolled 59 patients with COVID-19, including 38 moderate, 16 mild, and 5 asymptomatic patients; 31 (52.5%) were men and 28 (47.5%) were women. The median age was 41 years (interquartile range, 30-55). The median day from symptom onset to enrollment was 317 days (range 257 to 343 days). We found that approximately 90% of patients still have detectable immunoglobulin (Ig)G antibodies against spike and nucleocapsid proteins and neutralizing antibodies against pseudovirus, whereas ~60% of patients had detectable IgG antibodies against receptor-binding domain and surrogate virus-neutralizing antibodies. The SARS-CoV-2-specific IgG+ memory B cell and interferon-γ-secreting T cell responses were detectable in more than 70% of patients.
Conclusions: Severe acute respiratory syndrome coronavirus 2-specific immune memory response persists in most patients approximately 1 year after infection, which provides a promising sign for prevention from reinfection and vaccination strategy.
Keywords: SARS-CoV-2; memory B cell; memory T cell; neutralizing antibody; persistence.
【저자키워드】 neutralizing antibody, SARS-CoV-2, persistence, memory T cell, memory B cell, 【초록키워드】 COVID-19, coronavirus disease, neutralizing antibody, Coronavirus disease 2019, coronavirus, Neutralizing antibodies, antibody, cross-sectional, Infection, interferon, severe acute respiratory syndrome Coronavirus, nucleocapsid protein, Severe acute respiratory syndrome, Reinfection, T cell, cross-sectional study, IgG antibody, Receptor-binding domain, Asymptomatic, Immunoglobulin, IgG antibodies, pseudovirus, persistence, Patient, Mild, Neutralizing, immune memory, women, nucleoprotein, respiratory, moderate, patients, T cell response, memory T cell, memory B cell, Vaccination strategy, humoral, B cell response, symptom onset, interquartile range, acute respiratory syndrome, Enrollment, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, Most patients, median age, domain, Nucleocapsid proteins, spike and nucleocapsid proteins, virus-neutralizing antibodies, memory T, men, Cell, memory B, nucleoprotein of SARS-CoV-2, enrolled, analyzed, performed, detectable, median, provide, the receptor-binding domain, were measured, patients with COVID-19, persist, 【제목키워드】 response, over, Month,